🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/07/2002 | 42,27 | 43,79 | 41,32 | 43,46 | +2,87% | 5,85% | 12.063.004 |
| 11/07/2002 | 40,82 | 42,85 | 40,17 | 42,25 | +1,63% | 6,57% | 19.090.997 |
| 10/07/2002 | 43,42 | 43,42 | 41,36 | 41,57 | -4,77% | 4,73% | 19.899.110 |
| 09/07/2002 | 44,95 | 45,23 | 43,19 | 43,65 | -4,31% | 4,54% | 14.705.641 |
| 08/07/2002 | 44,83 | 46,09 | 44,47 | 45,62 | -2,15% | 3,62% | 19.903.721 |
| 05/07/2002 | 45,32 | 46,66 | 45,32 | 46,62 | +3,34% | 2,95% | 4.089.296 |
| 03/07/2002 | 44,51 | 45,11 | 44,44 | 45,11 | +0,77% | 1,52% | 10.632.694 |
| 02/07/2002 | 46,71 | 46,76 | 44,42 | 44,77 | -3,75% | 5,01% | 9.363.880 |
| 01/07/2002 | 48,56 | 48,75 | 46,28 | 46,52 | -3,73% | 5,09% | 6.790.935 |
| 28/06/2002 | 48,00 | 49,09 | 47,58 | 48,32 | -0,47% | 3,16% | 7.595.485 |
| 27/06/2002 | 48,00 | 48,66 | 47,22 | 48,55 | +1,09% | 3,00% | 6.733.505 |
| 26/06/2002 | 45,80 | 48,43 | 45,42 | 48,02 | +2,61% | 6,56% | 9.401.608 |
| 25/06/2002 | 46,54 | 47,85 | 46,44 | 46,80 | -0,91% | 3,03% | 8.564.885 |
| 24/06/2002 | 46,80 | 47,71 | 45,42 | 47,23 | -0,96% | 4,89% | 14.096.438 |
| 21/06/2002 | 47,95 | 48,86 | 47,47 | 47,69 | -4,25% | 2,89% | 16.015.746 |
| 20/06/2002 | 49,67 | 50,16 | 49,62 | 49,81 | -0,65% | 1,10% | 4.860.729 |
| 19/06/2002 | 50,11 | 51,05 | 49,91 | 50,13 | -0,79% | 2,27% | 5.440.482 |
| 18/06/2002 | 50,83 | 51,14 | 50,47 | 50,53 | -0,77% | 1,31% | 4.312.520 |
| 17/06/2002 | 50,11 | 51,40 | 49,72 | 50,93 | +1,64% | 3,35% | 5.623.254 |
| 14/06/2002 | 49,62 | 50,28 | 48,62 | 50,11 | +0,92% | 3,35% | 6.917.848 |
| 13/06/2002 | 49,43 | 50,67 | 48,83 | 49,65 | +0,08% | 3,73% | 7.312.001 |
| 12/06/2002 | 48,45 | 49,71 | 48,45 | 49,61 | +0,21% | 2,60% | 8.201.124 |
| 11/06/2002 | 50,95 | 51,53 | 49,26 | 49,50 | -4,46% | 4,46% | 9.967.842 |
| 10/06/2002 | 50,26 | 52,39 | 49,87 | 51,81 | +3,08% | 5,01% | 5.937.863 |
| 07/06/2002 | 49,86 | 50,72 | 49,63 | 50,27 | -0,98% | 2,18% | 10.016.889 |
| 06/06/2002 | 51,77 | 51,77 | 50,00 | 50,76 | -3,18% | 3,43% | 8.871.110 |
| 05/06/2002 | 52,43 | 52,47 | 51,58 | 52,43 | +0,55% | 1,69% | 4.803.718 |
| 04/06/2002 | 52,69 | 52,71 | 51,76 | 52,15 | -1,03% | 1,81% | 6.162.345 |
| 03/06/2002 | 54,44 | 54,57 | 52,53 | 52,69 | -3,29% | 3,75% | 5.310.740 |
| 31/05/2002 | 54,25 | 54,72 | 53,94 | 54,48 | +1,26% | 1,44% | 7.080.812 |